Polymyxin derivatives and their use in combination therapy together with different antibiotics
US10407467B2 · kind B2 · utility
2Cited by
4References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2014 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | May 21, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are compounds of formula (I) for use in combination treatment with a second active agent, such as rifampicin, for example for treatment of a microbial infection. The compound of formula (I) is a polymyxin compound is:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.